aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.42) per share from the same period last year.
Crypto Surge: Can You Price The Future? How Investors Are Valuing Digital Assets
Digital assets, such as Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH), have taken the